Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2025-12-24 @ 4:34 PM
NCT ID: NCT05119166
Eligibility Criteria: Inclusion Criteria: * CHILD Study: Full term healthy infant; singleton pregnancy; English literary * ELICIT Study: Adult mothers, child \<14 days, lives within 25km of Haydom * VITAL Study: Lactating, biological mothers * MISAMEIII Study: Confirmed (pregnancy test/ultrasound) pregnant women 15-40 years old, informed consent, self, parents or husband (for minors; assent). Exclusion Criteria: * CHILD Study: IVF; congenital abnormality; preterm delivery * ELICIT Study: Multiple gestation, birth defects/neonatal illness, weight \<1.5g, no intention to breastfeed, will move from area within 18 months * VITAL Study: Use of any ointments or topical solutions immediately prior to sampling, non-consent * MISAMEIII Study: Peanut allergy, gestational age \<20weeks, women who will not deliver babies in or live in study area by delivery date.
Sex: ALL
Minimum Age: 15 Years
Study: NCT05119166
Study Brief:
Protocol Section: NCT05119166